StockStory.org on MSN
Dentsply Sirona (XRAY) Stock Trades Up, Here Is Why
What Happened? Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) rose 1.1% in the afternoon session after the U ...
Now, in an SEC filing dated Oct. 14, Dentsply said the SEC concluded its investigation and doesn’t recommend any enforcement ...
Dentsply Sirona (XRAY) on Tuesday said that the U.S. Securities and Exchange Commission has ended its investigation into the ...
Dentsply Sirona shares gained after the Securities and Exchange Commission concluded its investigation of the company. The stock rose 7% to $13.30 in after-hours trading Tuesday. Through the close, ...
DENTSPLY SIRONA (XRAY) announced that the company plans to refocus the Byte business model around treatments that include expanded in-person dentist oversight. The Company is evaluating the ...
StockStory.org on MSN
Dentsply Sirona, Acadia Healthcare, and Haemonetics Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were ...
The integration enables automatic exchange of 2D X-ray data between DS Core and Second Opinion® chairside dental AI software. This seamless integration of DS Core, Dentsply Sirona’s cloud-based ...
Today we’ll look at DENTSPLY SIRONA Inc. (NASDAQ:XRAY) and reflect on its potential as an investment. In particular, we’ll consider its Return On Capital Employed (ROCE), as that can give us insight ...
ASP Isotopes is commencing an underwritten public offering. Shares fell 10% to $12.69 after the bell Tuesday. Dentsply Sirona said a Securities and Exchange Commission probe into its accounting ...
Ratings for Dentsply Sirona (NASDAQ:XRAY) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of ...
We believe Dentsply Sirona is in fine financial health. At the end of 2022, the firm had $365 million in cash and equivalents with about $2 billion in debt. The firm issued a $750 million of unsecured ...
In the last three months, 5 analysts have published ratings on Dentsply Sirona (NASDAQ: XRAY), offering a diverse range of perspectives from bullish to bearish.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results